Serum B hepatitis (BH) markers in blood donors in Venezuela. What do they mean?;Marcadores serológicos para hepatitis B (HB) en donantes venezolanos ¿Qué significan?

Sangre

Volumn 43, Issue 5, 1998, Pages 385-391

  León, Graciela ^a   Hernández, Teodoro ^a   García, Lisbeth ^a   Maio, Ana ^a   Quiroz, Ana ^a   Gamboa, Melania ^a  

^a Banco Munic Sangre Distrito Fed ^*  (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN;

ADULT; ANALYTICAL EQUIPMENT; ARTICLE; BLOOD; BLOOD DONOR; BLOOD TRANSFUSION; DISEASE TRANSMISSION; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HUMAN; MALE; PREVALENCE; RISK FACTOR; VENEZUELA;

ADULT; BIOLOGICAL MARKERS; BLOOD DONORS; BLOOD TRANSFUSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; PREVALENCE; REAGENT KITS, DIAGNOSTIC; RISK FACTORS; VENEZUELA;

EID: 0032177653     PISSN: 00364355     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. OMS y OPS . Paises Andinos. Taller sobre control de calidad de sangre en transfusiones: Serología para la detección de Hepatitis B, C, Sifílis, Tripanosomiasis Americana, VIH/Sida. Informe Final LimaPerú. Noviembre de 1993.
2. Schreiber G, Busch M, Kleinman S, Korelitz J, for the Retrovirus Epidemiology Donor Study. The risk of transfusion-transmitted viral infection. N Engl J Med 1996; 334: 1685-1690.
3. Beasley RP, Trepos C, Stevens CE, Szmuness W. The e antigen and vertical transmision of hepatitis B surface antigen. Am J Epidemiol 1977; 105:94-98.
4. Szmuness W, Much Y, Prince A, Hoofnagle J,Cherubin Ch, Harley E et al. On the role of sexual behavior in the spread of hepatitis B infection Ann Intern Med 1975; 83: 489-495.
5. The Incident Investigation Teams and Others. Transmission of hepatitis B to patients from infected surgeons without hepatitis B e antigen. N Engl J Med 1997; 336: 178-184.
6. Gerlich WT, Thomsson R. Los Virus de la hepatitis. Terminologia, estructura y diagnóstico de laboratorio de los virus de la hepatitis. En: Rodes J, Benhama J,Bircher J, Mclntyre N and Rizetto M. Tratado de hepatología clínica. Ediciones Cientificas y Técnicas SX. Salvat Medicina. Barcelona-España.1993; 626-659.
7. Mimms LT, Morley JW, Hollinger FB, Aach R, Stevens C, Cunningham M, et al. Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection. B M J 1993; 307: 1095-1097.
8. Busch M, Lee L, Satten G, Henrard D, Farzadegan H, Nelson K et al. Time course of detection of viral and serologic markers preceding human immunodeficiency virus type I seroconversion: implications for screening of blood and tissue donors. Transfusion 1995; 35: 91-97.
9. Dodd Roger. The risk of transfusion-transmitted infection. N Engl J Med 1992; 327: 419-420.
10. Fernández R, Machadp Y, Paulini H. Epidemiología de la hepatitis viral. Boletín de Salud Pública. Año XVIII, 59, 1985.
11. León G, Soré A, Celis S, Semprúm O, Acosta V, Gómez O Hepatitis post-transfusional. Estudio preliminar. Sangre 1991, 36: 93-97.
12. Hofnagle JH, Seeff LB, Bales ZB, Zimmerman HJ. Type B Hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med 1978; 298: 1379-1383.
13. Stevens CE, Aach RD, Hollinger FB, Mosley J,Szmuness W, Kahn R et al. Hepatitis B virus antibody in blood donors and the occurrence of non A non B hepatitis in transfusion recipients. An analysis of the Transfusion-Transmitted Viruses Study. Ann Intern Med 1984; 101: 733-738
14. Rakela J, Hollinger F, Aach R et al Transfusion Transmitted Viruses Study: risk of hepatitis B virus infection in recipients of screened blood. In: Szmuness W, Alter H, Maynard J eds. Viral hepatitis: 1981 International Symposium Philadelphia. Franklin Institute Press, 1982; 823-824.
15. Mosley J, Stevens C, Aach R, Hollinger F, Mimms L, Solomon L et al. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients. Transfusion 1995; 35: 5-12.
16. Koziol DE, Holland PV, Ailing DW, Melpolder J, Solomon L, Purcell R, el al. Antibody to hepatitis B core antigen a paradoxical marker for non A non B hepatitis agents in donate blood. Ann Intern Med 1986; 104: 488-495.
17. Aach RD, Szmuness W, Mosley J, Hollinger F, Kahn R, Stevens C, et al. Serum alanine transferase of donor in relation to the risk of non A non B hepatitis in recipients. The Transfusion Transmitted Viruses Study. N Engl J Med 1981; 304: 989-994.
18. Alter H, Purcell R, Holland P, Ailing D, Koziol D. Donortransaminase and recipient hepatitis Impact on blood transfusion services. JAMA 1981; 248: 630-634.
19. Guevara F, Suarez M, León G. Hepatitis B y C en niños leucémicos del Hospital J.M de los Ríos, Caracas. Biblioteca del Banco Municipal de Sangre, Universidad Central de Venezuela. 1993-1994.
20. Technical Manual. American Association of Blood Banks. 12th edition, 1996. Bethesda, Maryland.
21. Mahony J and Chernesky M. Vertical transmission of viral hepatitis. Trans Med Rew 1993; 7: 112-120.
22. Carvalho MR, KriegerMA, AlmeidaE, Oelemann W, Shikanai-Yassuda MA, Ferreira AW et al. Chagas's disease diagnosis: evaluation of several test in blood bank screening. Transfusion 1993; 33: 830-834.